Nuformix Cash Flow Statement

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-0.65	-3.64	-0.57	-0.76	-1.11
Depreciation & Amortization	0.03	0.03	0.04	0.04	0.04
Loss (Gain) From Sale of Assets	-	-	-0.02	-	-
Asset Writedown & Restructuring Costs	-	3.14	-	-	-
Stock-Based Compensation	-	0.01	0.02	0.02	0.02
Other Operating Activities	-0	0.06	0.06	0.16	-0.04
Change in Accounts Receivable	0	0.03	0.09	0.07	-0.17
Change in Accounts Payable	0.01	0.03	-0.01	0.04	-0.09
Operating Cash Flow	-0.61	-0.33	-0.4	-0.43	-1.35
Sale (Purchase) of Intangibles	-	-	0.03	-	-
Investing Cash Flow	-	-	0.03	-	-
Issuance of Common Stock	0.69	0.15	0.19	0.23	0.17
Other Financing Activities	-	-	-0	-	-0.03
Financing Cash Flow	0.69	0.15	0.19	0.23	0.14
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-
Net Cash Flow	0.08	-0.18	-0.17	-0.2	-1.21
Free Cash Flow	-0.61	-0.33	-0.4	-0.43	-1.35
Free Cash Flow Margin	-	-	-	-	-2691.33%
Free Cash Flow Per Share	-	-	-0.00	-0.00	-0.00
Cash Income Tax Paid	-0.01	-0.07	-0.11	-0.16	-0.12
Levered Free Cash Flow	-0.37	-0.15	-	-0.15	-1.03
Unlevered Free Cash Flow	-0.37	-0.15	-	-0.15	-1.03
Change in Working Capital	0.01	0.07	0.08	0.11	-0.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.